| | |
Before RT
|
After RT
|
Three years
| | | |
|---|
|
n
|
Md
|
IQR
|
Md
|
IQR
|
Md
|
IQR
|
p1
|
p2
|
p3
|
|---|
|
TGF-β1 (ng/ml)
|
63
|
19.2
|
(17.1–22.3)
|
18.8
|
(14.5–22.0)
|
17.2
|
(13.7–21.2)
|
0.003
|
0.001
|
0.101
|
|
PDGF (ng/ml)
|
63
|
15.4
|
(12.6–19.1)
|
13.8
|
(11.7–16.2)
|
15.6
|
(10.4–18.4)
|
0.001
|
0.046
|
0.661
|
|
proBNP (ng/l)
|
62
|
75.5
|
(42.5–125.5)
|
75.0
|
(35.5–132.8)
|
101.0
|
(55.5–183.3)
|
0.325
|
< 0.001
|
< 0.001
|
- TGF-β1 Transforming growth factor beta 1, PDGF Platelet-derived growth factor, proBNP N-terminal pro-brain natriuretic peptide, RT Radiotherapy, Md Median, IQR Interquartile range, p1 Change from before to after RT, p2 Change from before to 3 years after RT, p3 Change from after RT to 3 years after RT
